ArticleFrontiers in medicine2025

Proteomic alterations in ovarian cancer-Predicting residual disease status using artificial intelligence and SHAP-based biomarker interpretation.

Seyma Yasar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.